December 6th 2024
Lilly is investing $3 billion to expand its recently acquired manufacturing facility in Wisconsin, while Amgen is investing $1 billion to expand its facility in North Carolina.
Through the agreement, Cambrex will provide accelerated access to clinical development capabilities to Lilly’s biotech collaborators.
November 23rd 2024
The Thousand Oaks, Calif., cell therapy manufacturing facility now houses new production suites, updated development labs, and more after expansion.
The $3.6 million investment will allow the CDMO to boost its advanced labeling, automated visual inspection, and fill/finish capabilities.
November 22nd 2024
Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.
Outsourcing Outlook
The author discusses current economic times and conditions for large pharmaceutical companies.
The author looks ahead to what 2002 may have in store for the contract services industry.
Capacity is a pivotal commodity in the contract manufacturing business. If you have enough of the right kind of capacity, it's like platinum; conversely, too much of the wrong kind of capacity is like tin.
Recovery of the contract services industry picked up steam in the quarter ending 30 June 2001.
Six Sigma Can Give Contractors a Quality Advantage
This projectbased qualityimprovement program uses shortterm goals to achieve the longterm objectives of constant, continuous improvement.
The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.
Stakes Rise for Blown Batches
The vulnerability of both the sponsors and the contractors has increased tremendously.
The author reviews year-to-date progress and growth in the pharmaceutical outsourcing industry.